Dec 31, 2016

United Therapeutics Q4 2016 Earnings Report

Total Revenue
$409M
Previous year: $405M
+1.0%
EPS
$4.12
Previous year: $3.68
+12.0%
Gross Profit
$381M
Previous year: $380M
+0.3%
Cash and Equivalents
$1.02B
Previous year: $832M
+23.0%
Free Cash Flow
$149M
Previous year: $351M
-57.7%
Total Assets
$2.33B
Previous year: $2.18B
+6.5%

United Therapeutics

United Therapeutics